Australian Experts Debate Expansion of National Shingles Vaccination Program
Reported shingles cases have increased among Australians aged 25–49 over the last two decades. While the vaccine is free for older and high-risk groups, experts are divided on whether to expand public funding to younger cohorts.
Key takeaways
- Shingles cases among Australians aged 25–49 have increased over the last 20 years.
- The Shingrix vaccine costs approximately A$560 for those not eligible for the government's free program.
- Public health experts generally prioritize free vaccinations for those 65 and older due to higher risks of severe illness.
- Health authorities are investigating whether the rise in younger cases is due to increased reporting or a genuine change in viral behavior.
What Happened
In Australia, medical data shows a rise in reported cases of herpes zoster, commonly known as shingles, among adults between the ages of 25 and 49 over the past 20 years. Shingles occurs when the varicella-zoster virus, which causes chickenpox, reactivates after lying dormant in nerve tissues. While older adults face the highest risk of hospitalization and severe illness, the increase in cases among younger populations has prompted a debate regarding the accessibility of the Shingrix vaccine.
Background
The current National Immunisation Program provides free shingles vaccinations to specific high-risk groups: individuals aged 65 and older, Aboriginal and Torres Strait Islander people aged 50 and older, and immunocompromised adults aged 18 and older. For individuals who do not meet these criteria, the cost of the two-dose vaccine course is approximately A$560. While vaccination is recommended for all adults over 50, those outside the eligibility groups must pay for the procedure privately.
Key Facts
- Shingles is caused by the reactivation of the dormant chickenpox virus and can occur multiple times in one individual.
- Reported cases in the 25–49 age bracket have risen over the last two decades, though it is unclear if this reflects a genuine increase in incidence or improved reporting standards.
- The cost for a private two-dose shingles vaccination course in Australia is roughly A$560.
- Older adults are at the highest risk for severe illness and hospitalization due to the virus.
- Out of five medical experts consulted on expanding the free program to all adults, four argued against the expansion while one supported it.
Why It Matters
The debate highlights the tension between public health budgets and preventative care for younger populations. Expanding the program would require significant government funding, and most experts currently prioritize resources for those most likely to suffer severe complications. However, the rise in cases among younger adults suggests that the dormant virus is reactivating earlier in the modern population, raising questions about future immunity trends and the economic impact of nerve-pain-related illness in the workforce.
Story by Project Chintan
Related stories
Australian Research Highlights Parent Demand for Transparent Childcare Safety Data
Coroner Identifies Protocol Failures in Care Home Fall Death After Scripts 'Downplayed' Injury
Chemical Mechanics for Removing Persistent Bathroom Biofilms
